0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gaucher's Disease Oral Therapy Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-17E18595
Home | Market Reports | Health| Health Conditions
Global Gaucher s Disease Oral Therapy Market Research Report 2024
BUY CHAPTERS

Global Gaucher's Disease Oral Therapy Market Research Report 2024

Code: QYRE-Auto-17E18595
Report
October 2024
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gaucher's Disease Oral Therapy Market

Gaucher's disease is a genetic disorder characterized by the accumulation of glucocerebroside due to a deficiency of the enzyme glucocerebrosidase. Oral therapy for Gaucher's disease involves the use of substrate reduction therapy (SRT), specifically medications like eliglustat, which reduce the production of glucocerebroside, thereby helping to manage symptoms and prevent complications associated with the disease.
The global Gaucher's Disease Oral Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Gaucher's Disease Oral Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gaucher's Disease Oral Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Gaucher's Disease Oral Therapy include Sanofi, Actelion Pharmaceuticals, Edenbridge Pharmaceuticals, Amerigen Pharmaceuticals, Breckenridge Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gaucher's Disease Oral Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gaucher's Disease Oral Therapy.
The Gaucher's Disease Oral Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Gaucher's Disease Oral Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gaucher's Disease Oral Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gaucher's Disease Oral Therapy Market Report

Report Metric Details
Report Name Gaucher's Disease Oral Therapy Market
Segment by Type
Segment by Application
  • Hospital and Clinic
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Actelion Pharmaceuticals, Edenbridge Pharmaceuticals, Amerigen Pharmaceuticals, Breckenridge Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gaucher's Disease Oral Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gaucher's Disease Oral Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Gaucher's Disease Oral Therapy Market report?

Ans: The main players in the Gaucher's Disease Oral Therapy Market are Sanofi, Actelion Pharmaceuticals, Edenbridge Pharmaceuticals, Amerigen Pharmaceuticals, Breckenridge Pharmaceutical

What are the Application segmentation covered in the Gaucher's Disease Oral Therapy Market report?

Ans: The Applications covered in the Gaucher's Disease Oral Therapy Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the Gaucher's Disease Oral Therapy Market report?

Ans: The Types covered in the Gaucher's Disease Oral Therapy Market report are Miglustat, Eliglustat, Other

Recommended Reports

Rare Disease Treatments

Oral Disease Solutions

Metabolic Disorder Drugs

1 Gaucher's Disease Oral Therapy Market Overview
1.1 Product Definition
1.2 Gaucher's Disease Oral Therapy by Type
1.2.1 Global Gaucher's Disease Oral Therapy Market Value Comparison by Type (2024-2030)
1.2.2 Miglustat
1.2.3 Eliglustat
1.2.4 Other
1.3 Gaucher's Disease Oral Therapy by Application
1.3.1 Global Gaucher's Disease Oral Therapy Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Gaucher's Disease Oral Therapy Market Size Estimates and Forecasts
1.4.1 Global Gaucher's Disease Oral Therapy Revenue 2019-2030
1.4.2 Global Gaucher's Disease Oral Therapy Sales 2019-2030
1.4.3 Global Gaucher's Disease Oral Therapy Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gaucher's Disease Oral Therapy Market Competition by Manufacturers
2.1 Global Gaucher's Disease Oral Therapy Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gaucher's Disease Oral Therapy Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gaucher's Disease Oral Therapy Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Gaucher's Disease Oral Therapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gaucher's Disease Oral Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gaucher's Disease Oral Therapy, Product Type & Application
2.7 Global Key Manufacturers of Gaucher's Disease Oral Therapy, Date of Enter into This Industry
2.8 Global Gaucher's Disease Oral Therapy Market Competitive Situation and Trends
2.8.1 Global Gaucher's Disease Oral Therapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gaucher's Disease Oral Therapy Players Market Share by Revenue
2.8.3 Global Gaucher's Disease Oral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gaucher's Disease Oral Therapy Market Scenario by Region
3.1 Global Gaucher's Disease Oral Therapy Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gaucher's Disease Oral Therapy Sales by Region: 2019-2030
3.2.1 Global Gaucher's Disease Oral Therapy Sales by Region: 2019-2024
3.2.2 Global Gaucher's Disease Oral Therapy Sales by Region: 2025-2030
3.3 Global Gaucher's Disease Oral Therapy Revenue by Region: 2019-2030
3.3.1 Global Gaucher's Disease Oral Therapy Revenue by Region: 2019-2024
3.3.2 Global Gaucher's Disease Oral Therapy Revenue by Region: 2025-2030
3.4 North America Gaucher's Disease Oral Therapy Market Facts & Figures by Country
3.4.1 North America Gaucher's Disease Oral Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gaucher's Disease Oral Therapy Sales by Country (2019-2030)
3.4.3 North America Gaucher's Disease Oral Therapy Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gaucher's Disease Oral Therapy Market Facts & Figures by Country
3.5.1 Europe Gaucher's Disease Oral Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gaucher's Disease Oral Therapy Sales by Country (2019-2030)
3.5.3 Europe Gaucher's Disease Oral Therapy Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gaucher's Disease Oral Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific Gaucher's Disease Oral Therapy Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gaucher's Disease Oral Therapy Sales by Region (2019-2030)
3.6.3 Asia Pacific Gaucher's Disease Oral Therapy Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gaucher's Disease Oral Therapy Market Facts & Figures by Country
3.7.1 Latin America Gaucher's Disease Oral Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gaucher's Disease Oral Therapy Sales by Country (2019-2030)
3.7.3 Latin America Gaucher's Disease Oral Therapy Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Gaucher's Disease Oral Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Gaucher's Disease Oral Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gaucher's Disease Oral Therapy Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gaucher's Disease Oral Therapy Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gaucher's Disease Oral Therapy Sales by Type (2019-2030)
4.1.1 Global Gaucher's Disease Oral Therapy Sales by Type (2019-2024)
4.1.2 Global Gaucher's Disease Oral Therapy Sales by Type (2025-2030)
4.1.3 Global Gaucher's Disease Oral Therapy Sales Market Share by Type (2019-2030)
4.2 Global Gaucher's Disease Oral Therapy Revenue by Type (2019-2030)
4.2.1 Global Gaucher's Disease Oral Therapy Revenue by Type (2019-2024)
4.2.2 Global Gaucher's Disease Oral Therapy Revenue by Type (2025-2030)
4.2.3 Global Gaucher's Disease Oral Therapy Revenue Market Share by Type (2019-2030)
4.3 Global Gaucher's Disease Oral Therapy Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gaucher's Disease Oral Therapy Sales by Application (2019-2030)
5.1.1 Global Gaucher's Disease Oral Therapy Sales by Application (2019-2024)
5.1.2 Global Gaucher's Disease Oral Therapy Sales by Application (2025-2030)
5.1.3 Global Gaucher's Disease Oral Therapy Sales Market Share by Application (2019-2030)
5.2 Global Gaucher's Disease Oral Therapy Revenue by Application (2019-2030)
5.2.1 Global Gaucher's Disease Oral Therapy Revenue by Application (2019-2024)
5.2.2 Global Gaucher's Disease Oral Therapy Revenue by Application (2025-2030)
5.2.3 Global Gaucher's Disease Oral Therapy Revenue Market Share by Application (2019-2030)
5.3 Global Gaucher's Disease Oral Therapy Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Gaucher's Disease Oral Therapy Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Gaucher's Disease Oral Therapy Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Actelion Pharmaceuticals
6.2.1 Actelion Pharmaceuticals Company Information
6.2.2 Actelion Pharmaceuticals Description and Business Overview
6.2.3 Actelion Pharmaceuticals Gaucher's Disease Oral Therapy Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Actelion Pharmaceuticals Gaucher's Disease Oral Therapy Product Portfolio
6.2.5 Actelion Pharmaceuticals Recent Developments/Updates
6.3 Edenbridge Pharmaceuticals
6.3.1 Edenbridge Pharmaceuticals Company Information
6.3.2 Edenbridge Pharmaceuticals Description and Business Overview
6.3.3 Edenbridge Pharmaceuticals Gaucher's Disease Oral Therapy Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Edenbridge Pharmaceuticals Gaucher's Disease Oral Therapy Product Portfolio
6.3.5 Edenbridge Pharmaceuticals Recent Developments/Updates
6.4 Amerigen Pharmaceuticals
6.4.1 Amerigen Pharmaceuticals Company Information
6.4.2 Amerigen Pharmaceuticals Description and Business Overview
6.4.3 Amerigen Pharmaceuticals Gaucher's Disease Oral Therapy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amerigen Pharmaceuticals Gaucher's Disease Oral Therapy Product Portfolio
6.4.5 Amerigen Pharmaceuticals Recent Developments/Updates
6.5 Breckenridge Pharmaceutical
6.5.1 Breckenridge Pharmaceutical Company Information
6.5.2 Breckenridge Pharmaceutical Description and Business Overview
6.5.3 Breckenridge Pharmaceutical Gaucher's Disease Oral Therapy Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Breckenridge Pharmaceutical Gaucher's Disease Oral Therapy Product Portfolio
6.5.5 Breckenridge Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gaucher's Disease Oral Therapy Industry Chain Analysis
7.2 Gaucher's Disease Oral Therapy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gaucher's Disease Oral Therapy Production Mode & Process
7.4 Gaucher's Disease Oral Therapy Sales and Marketing
7.4.1 Gaucher's Disease Oral Therapy Sales Channels
7.4.2 Gaucher's Disease Oral Therapy Distributors
7.5 Gaucher's Disease Oral Therapy Customers
8 Gaucher's Disease Oral Therapy Market Dynamics
8.1 Gaucher's Disease Oral Therapy Industry Trends
8.2 Gaucher's Disease Oral Therapy Market Drivers
8.3 Gaucher's Disease Oral Therapy Market Challenges
8.4 Gaucher's Disease Oral Therapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Gaucher's Disease Oral Therapy Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Gaucher's Disease Oral Therapy Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Gaucher's Disease Oral Therapy Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Gaucher's Disease Oral Therapy Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Gaucher's Disease Oral Therapy Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Gaucher's Disease Oral Therapy Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Gaucher's Disease Oral Therapy Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Gaucher's Disease Oral Therapy Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Gaucher's Disease Oral Therapy, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gaucher's Disease Oral Therapy, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gaucher's Disease Oral Therapy, Product Type & Application
 Table 12. Global Key Manufacturers of Gaucher's Disease Oral Therapy, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gaucher's Disease Oral Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gaucher's Disease Oral Therapy as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gaucher's Disease Oral Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Gaucher's Disease Oral Therapy Sales by Region (2019-2024) & (K Units)
 Table 18. Global Gaucher's Disease Oral Therapy Sales Market Share by Region (2019-2024)
 Table 19. Global Gaucher's Disease Oral Therapy Sales by Region (2025-2030) & (K Units)
 Table 20. Global Gaucher's Disease Oral Therapy Sales Market Share by Region (2025-2030)
 Table 21. Global Gaucher's Disease Oral Therapy Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Gaucher's Disease Oral Therapy Revenue Market Share by Region (2019-2024)
 Table 23. Global Gaucher's Disease Oral Therapy Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Gaucher's Disease Oral Therapy Revenue Market Share by Region (2025-2030)
 Table 25. North America Gaucher's Disease Oral Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Gaucher's Disease Oral Therapy Sales by Country (2019-2024) & (K Units)
 Table 27. North America Gaucher's Disease Oral Therapy Sales by Country (2025-2030) & (K Units)
 Table 28. North America Gaucher's Disease Oral Therapy Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Gaucher's Disease Oral Therapy Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Gaucher's Disease Oral Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Gaucher's Disease Oral Therapy Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Gaucher's Disease Oral Therapy Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Gaucher's Disease Oral Therapy Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Gaucher's Disease Oral Therapy Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Gaucher's Disease Oral Therapy Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Gaucher's Disease Oral Therapy Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Gaucher's Disease Oral Therapy Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Gaucher's Disease Oral Therapy Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Gaucher's Disease Oral Therapy Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Gaucher's Disease Oral Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Gaucher's Disease Oral Therapy Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Gaucher's Disease Oral Therapy Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Gaucher's Disease Oral Therapy Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Gaucher's Disease Oral Therapy Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Gaucher's Disease Oral Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Gaucher's Disease Oral Therapy Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Gaucher's Disease Oral Therapy Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Gaucher's Disease Oral Therapy Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Gaucher's Disease Oral Therapy Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Gaucher's Disease Oral Therapy Sales (K Units) by Type (2019-2024)
 Table 51. Global Gaucher's Disease Oral Therapy Sales (K Units) by Type (2025-2030)
 Table 52. Global Gaucher's Disease Oral Therapy Sales Market Share by Type (2019-2024)
 Table 53. Global Gaucher's Disease Oral Therapy Sales Market Share by Type (2025-2030)
 Table 54. Global Gaucher's Disease Oral Therapy Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Gaucher's Disease Oral Therapy Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Gaucher's Disease Oral Therapy Revenue Market Share by Type (2019-2024)
 Table 57. Global Gaucher's Disease Oral Therapy Revenue Market Share by Type (2025-2030)
 Table 58. Global Gaucher's Disease Oral Therapy Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Gaucher's Disease Oral Therapy Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Gaucher's Disease Oral Therapy Sales (K Units) by Application (2019-2024)
 Table 61. Global Gaucher's Disease Oral Therapy Sales (K Units) by Application (2025-2030)
 Table 62. Global Gaucher's Disease Oral Therapy Sales Market Share by Application (2019-2024)
 Table 63. Global Gaucher's Disease Oral Therapy Sales Market Share by Application (2025-2030)
 Table 64. Global Gaucher's Disease Oral Therapy Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Gaucher's Disease Oral Therapy Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Gaucher's Disease Oral Therapy Revenue Market Share by Application (2019-2024)
 Table 67. Global Gaucher's Disease Oral Therapy Revenue Market Share by Application (2025-2030)
 Table 68. Global Gaucher's Disease Oral Therapy Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Gaucher's Disease Oral Therapy Price (US$/Unit) by Application (2025-2030)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Gaucher's Disease Oral Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Sanofi Gaucher's Disease Oral Therapy Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Actelion Pharmaceuticals Company Information
 Table 76. Actelion Pharmaceuticals Description and Business Overview
 Table 77. Actelion Pharmaceuticals Gaucher's Disease Oral Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Actelion Pharmaceuticals Gaucher's Disease Oral Therapy Product
 Table 79. Actelion Pharmaceuticals Recent Developments/Updates
 Table 80. Edenbridge Pharmaceuticals Company Information
 Table 81. Edenbridge Pharmaceuticals Description and Business Overview
 Table 82. Edenbridge Pharmaceuticals Gaucher's Disease Oral Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Edenbridge Pharmaceuticals Gaucher's Disease Oral Therapy Product
 Table 84. Edenbridge Pharmaceuticals Recent Developments/Updates
 Table 85. Amerigen Pharmaceuticals Company Information
 Table 86. Amerigen Pharmaceuticals Description and Business Overview
 Table 87. Amerigen Pharmaceuticals Gaucher's Disease Oral Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Amerigen Pharmaceuticals Gaucher's Disease Oral Therapy Product
 Table 89. Amerigen Pharmaceuticals Recent Developments/Updates
 Table 90. Breckenridge Pharmaceutical Company Information
 Table 91. Breckenridge Pharmaceutical Description and Business Overview
 Table 92. Breckenridge Pharmaceutical Gaucher's Disease Oral Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Breckenridge Pharmaceutical Gaucher's Disease Oral Therapy Product
 Table 94. Breckenridge Pharmaceutical Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Gaucher's Disease Oral Therapy Distributors List
 Table 98. Gaucher's Disease Oral Therapy Customers List
 Table 99. Gaucher's Disease Oral Therapy Market Trends
 Table 100. Gaucher's Disease Oral Therapy Market Drivers
 Table 101. Gaucher's Disease Oral Therapy Market Challenges
 Table 102. Gaucher's Disease Oral Therapy Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gaucher's Disease Oral Therapy
 Figure 2. Global Gaucher's Disease Oral Therapy Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Gaucher's Disease Oral Therapy Market Share by Type: 2023 & 2030
 Figure 4. Miglustat Product Picture
 Figure 5. Eliglustat Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Gaucher's Disease Oral Therapy Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Gaucher's Disease Oral Therapy Market Share by Application: 2023 & 2030
 Figure 9. Hospital and Clinic
 Figure 10. Pharmacy
 Figure 11. Other
 Figure 12. Global Gaucher's Disease Oral Therapy Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Gaucher's Disease Oral Therapy Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Gaucher's Disease Oral Therapy Sales (2019-2030) & (K Units)
 Figure 15. Global Gaucher's Disease Oral Therapy Average Price (US$/Unit) & (2019-2030)
 Figure 16. Gaucher's Disease Oral Therapy Report Years Considered
 Figure 17. Gaucher's Disease Oral Therapy Sales Share by Manufacturers in 2023
 Figure 18. Global Gaucher's Disease Oral Therapy Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Gaucher's Disease Oral Therapy Players: Market Share by Revenue in Gaucher's Disease Oral Therapy in 2023
 Figure 20. Gaucher's Disease Oral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Gaucher's Disease Oral Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Gaucher's Disease Oral Therapy Sales Market Share by Country (2019-2030)
 Figure 23. North America Gaucher's Disease Oral Therapy Revenue Market Share by Country (2019-2030)
 Figure 24. United States Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Gaucher's Disease Oral Therapy Sales Market Share by Country (2019-2030)
 Figure 27. Europe Gaucher's Disease Oral Therapy Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Gaucher's Disease Oral Therapy Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Gaucher's Disease Oral Therapy Revenue Market Share by Region (2019-2030)
 Figure 35. China Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Gaucher's Disease Oral Therapy Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Gaucher's Disease Oral Therapy Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Gaucher's Disease Oral Therapy Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Gaucher's Disease Oral Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Gaucher's Disease Oral Therapy by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Gaucher's Disease Oral Therapy by Type (2019-2030)
 Figure 54. Global Gaucher's Disease Oral Therapy Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Gaucher's Disease Oral Therapy by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Gaucher's Disease Oral Therapy by Application (2019-2030)
 Figure 57. Global Gaucher's Disease Oral Therapy Price (US$/Unit) by Application (2019-2030)
 Figure 58. Gaucher's Disease Oral Therapy Value Chain
 Figure 59. Gaucher's Disease Oral Therapy Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart